Volume 168, Issue 3

Search all Journal of Neuro-Oncology articles

July 2024

19 articles in this issue

Constitutive type-1 interferons signaling activity in malignant gliomas
Chunzhao Li
Lang Long
Nan Ji
Research 24 May 2024 Pages: 381 - 391
Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort
Takahiro Ono
Hayato Suzuki
Hiroaki Shimizu
Research 23 May 2024 Pages: 393 - 404
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series
Arthur Araújo Massoud Salame
Helaine Laiz Silva Charchar
Maria Candida Barisson Villares Fragoso
Research 17 April 2024 Pages: 405 - 413
Impact of concurrent antibody–drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study
Yutaro Koide
Naoya Nagai
Takeshi Kodaira
Research 22 April 2024 Pages: 415 - 423
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model
Katharina Conrad
Ronja Löber-Handwerker
Vesna Malinova
Research Open access 19 April 2024 Pages: 425 - 433
Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center
David P. Bray
Nolan M. Stubbs
Kimberly B. Hoang
Research 04 June 2024 Pages: 435 - 443
Intraoperative radiotherapy combined with spinal stabilization surgery—a novel treatment strategy for spinal metastases based on a first single-center experiences
P. Krauss
C. L. Wolfert
E. Shiban
Research Open access 23 April 2024 Pages: 445 - 455
Part of 1 collection:

Innovation and Technology in Neurosurgical Oncology
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy
Ting Sun
Bin Liu
Yanyan Li
Research 23 April 2024 Pages: 457 - 471
Treatment, healthcare utilization and outcomes in patients with glioblastoma in Ontario: a 10-year cohort study
Wafa Baqri
Kathryn Rzadki
Sunit Das
Research 03 May 2024 Pages: 473 - 485
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator
Ryosuke Matsuda
Ryosuke Maeoka
Ichiro Nakagawa
Research 25 April 2024 Pages: 487 - 494
Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)
Iulia Peciu-Florianu
Quentin Vannod-Michel
Nicolas Reyns
Research Open access 16 May 2024 Pages: 495 - 505
Use of complementary therapies and supportive measures of patients with intracranial gliomas—a prospective evaluation in an outpatient clinic
Malte Ottenhausen
Mirjam Renovanz
Florian Ringel
Research Open access 06 May 2024 Pages: 507 - 513
Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data
Arya Shetty
Su Wang
Akdes Serin Harmanci
Research 29 May 2024 Pages: 515 - 524
Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data
Arya Shetty
Su Wang
Akdes Serin Harmanci
Correction 04 June 2024 Pages: 525 - 525
Single versus multiple reoperations for recurrent intracranial meningiomas
Francesco Maiuri
Sergio Corvino
Marialaura Del Basso De Caro
Case Study Open access 24 April 2024 Pages: 527 - 535
Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease
Anna Laura Knoblauch
B.-I. Blaß
J.-H. Klingler
Case Study Open access 22 April 2024 Pages: 537 - 545
Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study
Victor Goulenko
Venkatesh Shankar Madhugiri
Dheerendra Prasad
Case Study 15 May 2024 Pages: 547 - 553
Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations
Erasmo Barros da Silva Jr
Ricardo Ramina
Maurício Coelho Neto
Case Study 06 May 2024 Pages: 555 - 562
Part of 1 collection:

Innovation and Technology in Neurosurgical Oncology
Reply to “Elevating the findings by substituting in ‘ISarcoPRM’”
Li Feng Tan
Mervyn Lim
Correspondence 07 May 2024 Pages: 563 - 564

Volume 168, Issue 3

Constitutive type-1 interferons signaling activity in malignant gliomas

Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort

Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series

Impact of concurrent antibody–drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center

Intraoperative radiotherapy combined with spinal stabilization surgery—a novel treatment strategy for spinal metastases based on a first single-center experiences

Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy

Treatment, healthcare utilization and outcomes in patients with glioblastoma in Ontario: a 10-year cohort study

Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator

Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)

Use of complementary therapies and supportive measures of patients with intracranial gliomas—a prospective evaluation in an outpatient clinic

Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data

Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data

Single versus multiple reoperations for recurrent intracranial meningiomas

Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease

Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study

Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations

Reply to “Elevating the findings by substituting in ‘ISarcoPRM’”

Navigation